Logo image of ABLD.PA

ABL DIAGNOSTICS (ABLD.PA) Stock Fundamental Analysis

Europe - EPA:ABLD - FR001400AHX6 - Common Stock

3.9 EUR
+0.5 (+14.71%)
Last: 11/12/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, ABLD scores 4 out of 10 in our fundamental rating. ABLD was compared to 15 industry peers in the Trading Companies & Distributors industry. While ABLD seems to be doing ok healthwise, there are quite some concerns on its profitability. ABLD is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ABLD had positive earnings in the past year.
ABLD had positive earnings in 4 of the past 5 years.
In the past 5 years ABLD reported 4 times negative operating cash flow.
ABLD.PA Yearly Net Income VS EBIT VS OCF VS FCFABLD.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M

1.2 Ratios

The Return On Assets of ABLD (4.17%) is better than 73.33% of its industry peers.
ABLD has a Return On Equity (6.69%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 4.17%
ROE 6.69%
ROIC N/A
ROA(3y)3.32%
ROA(5y)3.14%
ROE(3y)6.99%
ROE(5y)5.41%
ROIC(3y)N/A
ROIC(5y)N/A
ABLD.PA Yearly ROA, ROE, ROICABLD.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

ABLD has a Profit Margin of 8.51%. This is amongst the best in the industry. ABLD outperforms 93.33% of its industry peers.
The Operating Margin and Gross Margin are not available for ABLD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 8.51%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ABLD.PA Yearly Profit, Operating, Gross MarginsABLD.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300 400

More info and screens

6

2. Health

2.1 Basic Checks

ABLD does not have a ROIC to compare to the WACC, probably because it is not profitable.
ABLD has about the same amout of shares outstanding than it did 1 year ago.
ABLD has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ABLD has an improved debt to assets ratio.
ABLD.PA Yearly Shares OutstandingABLD.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ABLD.PA Yearly Total Debt VS Total AssetsABLD.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

ABLD has an Altman-Z score of 10.20. This indicates that ABLD is financially healthy and has little risk of bankruptcy at the moment.
ABLD has a better Altman-Z score (10.20) than 100.00% of its industry peers.
ABLD has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
ABLD's Debt to Equity ratio of 0.26 is fine compared to the rest of the industry. ABLD outperforms 73.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z 10.2
ROIC/WACCN/A
WACC7.94%
ABLD.PA Yearly LT Debt VS Equity VS FCFABLD.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M

2.3 Liquidity

ABLD has a Current Ratio of 3.26. This indicates that ABLD is financially healthy and has no problem in meeting its short term obligations.
ABLD has a Current ratio of 3.26. This is amongst the best in the industry. ABLD outperforms 93.33% of its industry peers.
A Quick Ratio of 2.91 indicates that ABLD has no problem at all paying its short term obligations.
ABLD has a better Quick ratio (2.91) than 93.33% of its industry peers.
Industry RankSector Rank
Current Ratio 3.26
Quick Ratio 2.91
ABLD.PA Yearly Current Assets VS Current LiabilitesABLD.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

5

3. Growth

3.1 Past

ABLD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 150.43%, which is quite impressive.
ABLD shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -48.36% yearly.
ABLD shows a decrease in Revenue. In the last year, the revenue decreased by -7.68%.
EPS 1Y (TTM)150.43%
EPS 3Y-48.36%
EPS 5YN/A
EPS Q2Q%160.87%
Revenue 1Y (TTM)-7.68%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.32%

3.2 Future

ABLD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.42% yearly.
The Revenue is expected to grow by 41.75% on average over the next years. This is a very strong growth
EPS Next Y100%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year34.37%
Revenue Next 2Y41.75%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ABLD.PA Yearly Revenue VS EstimatesABLD.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2022 2023 2024 2025 2026 2M 4M 6M 8M 10M
ABLD.PA Yearly EPS VS EstimatesABLD.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0.02 0.04 0.06

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 130.00 indicates a quite expensive valuation of ABLD.
60.00% of the companies in the same industry are cheaper than ABLD, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of ABLD to the average of the S&P500 Index (26.34), we can say ABLD is valued expensively.
With a Price/Forward Earnings ratio of 63.73, ABLD can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, ABLD is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
ABLD is valuated expensively when we compare the Price/Forward Earnings ratio to 34.43, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 130
Fwd PE 63.73
ABLD.PA Price Earnings VS Forward Price EarningsABLD.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ABLD.PA Per share dataABLD.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.1 0.2 0.3 0.4

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ABLD's earnings are expected to grow with 41.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.3
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3YN/A

More info and screens

1

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.60%, ABLD has a reasonable but not impressive dividend return.
ABLD's Dividend Yield is slightly below the industry average, which is at 2.91.
Compared to the average S&P500 Dividend Yield of 2.36, ABLD is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.6%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ABLD.PA Yearly Dividends per shareABLD.PA Yearly Dividends per shareYearly Dividends per share 2025 0.01 0.02 0.03 0.04

5.3 Sustainability

DPN/A
EPS Next 2Y41.42%
EPS Next 3YN/A
ABLD.PA Yearly Income VS Free CF VS DividendABLD.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M

More info and screens

ABL DIAGNOSTICS

EPA:ABLD (11/12/2025, 7:00:00 PM)

3.9

+0.5 (+14.71%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners99.24%
Ins Owner ChangeN/A
Market Cap62.83M
Revenue(TTM)5.45M
Net Income(TTM)463.40K
Analysts85.71
Price Target6.28 (61.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.6%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 130
Fwd PE 63.73
P/S 11.53
P/FCF N/A
P/OCF N/A
P/B 9.07
P/tB 15.06
EV/EBITDA N/A
EPS(TTM)0.03
EY0.77%
EPS(NY)0.06
Fwd EY1.57%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.34
BVpS0.43
TBVpS0.26
PEG (NY)1.3
PEG (5Y)N/A
Graham Number0.54
Profitability
Industry RankSector Rank
ROA 4.17%
ROE 6.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 8.51%
GM N/A
FCFM N/A
ROA(3y)3.32%
ROA(5y)3.14%
ROE(3y)6.99%
ROE(5y)5.41%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.26
Quick Ratio 2.91
Altman-Z 10.2
F-ScoreN/A
WACC7.94%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)150.43%
EPS 3Y-48.36%
EPS 5YN/A
EPS Q2Q%160.87%
EPS Next Y100%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.68%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.32%
Revenue Next Year34.37%
Revenue Next 2Y41.75%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y51.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year789.36%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

ABL DIAGNOSTICS / ABLD.PA FAQ

What is the ChartMill fundamental rating of ABL DIAGNOSTICS (ABLD.PA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ABLD.PA.


What is the valuation status for ABLD stock?

ChartMill assigns a valuation rating of 1 / 10 to ABL DIAGNOSTICS (ABLD.PA). This can be considered as Overvalued.


What is the profitability of ABLD stock?

ABL DIAGNOSTICS (ABLD.PA) has a profitability rating of 2 / 10.


What is the financial health of ABL DIAGNOSTICS (ABLD.PA) stock?

The financial health rating of ABL DIAGNOSTICS (ABLD.PA) is 6 / 10.


What is the earnings growth outlook for ABL DIAGNOSTICS?

The Earnings per Share (EPS) of ABL DIAGNOSTICS (ABLD.PA) is expected to grow by 100% in the next year.